195 related articles for article (PubMed ID: 19236383)
1. Plasma calcitonin gene-related peptide in diagnosing and predicting paediatric migraine.
Fan PC; Kuo PH; Chang SH; Lee WT; Wu RM; Chiou LC
Cephalalgia; 2009 Aug; 29(8):883-90. PubMed ID: 19236383
[TBL] [Abstract][Full Text] [Related]
2. No increase of calcitonin gene-related peptide in jugular blood during migraine.
Tvedskov JF; Lipka K; Ashina M; Iversen HK; Schifter S; Olesen J
Ann Neurol; 2005 Oct; 58(4):561-8. PubMed ID: 16178016
[TBL] [Abstract][Full Text] [Related]
3. Calcitonin gene-related peptide and size of the atrial septal defect in new-onset migraine after transcatheter closure: results of a preliminary study.
Wei SH; Fan PC; Kuo PH; Chiou LC; Wang JK
Headache; 2012 Jun; 52(6):985-92. PubMed ID: 22486257
[TBL] [Abstract][Full Text] [Related]
4. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine.
Cernuda-Morollón E; Larrosa D; Ramón C; Vega J; Martínez-Camblor P; Pascual J
Neurology; 2013 Oct; 81(14):1191-6. PubMed ID: 23975872
[TBL] [Abstract][Full Text] [Related]
5. CGRP and VIP levels as predictors of efficacy of Onabotulinumtoxin type A in chronic migraine.
Cernuda-Morollón E; Martínez-Camblor P; Ramón C; Larrosa D; Serrano-Pertierra E; Pascual J
Headache; 2014 Jun; 54(6):987-95. PubMed ID: 24673487
[TBL] [Abstract][Full Text] [Related]
6. Elevated saliva calcitonin gene-related peptide levels during acute migraine predict therapeutic response to rizatriptan.
Cady RK; Vause CV; Ho TW; Bigal ME; Durham PL
Headache; 2009 Oct; 49(9):1258-66. PubMed ID: 19788468
[TBL] [Abstract][Full Text] [Related]
7. Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin induced migraine attack.
Juhasz G; Zsombok T; Jakab B; Nemeth J; Szolcsanyi J; Bagdy G
Cephalalgia; 2005 Mar; 25(3):179-83. PubMed ID: 15689192
[TBL] [Abstract][Full Text] [Related]
8. Endothelial progenitor cells: a new key for endothelial dysfunction in migraine.
Rodríguez-Osorio X; Sobrino T; Brea D; Martínez F; Castillo J; Leira R
Neurology; 2012 Jul; 79(5):474-9. PubMed ID: 22815557
[TBL] [Abstract][Full Text] [Related]
9. Plasma changes of calcitonin gene-related peptide and substance P in patients with dialysis headache.
Alessandri M; Massanti L; Geppetti P; Bellucci G; Cipriani M; Fanciullacci M
Cephalalgia; 2006 Nov; 26(11):1287-93. PubMed ID: 17059435
[TBL] [Abstract][Full Text] [Related]
10. Chemokine levels in the jugular venous blood of migraine without aura patients during attacks.
Sarchielli P; Alberti A; Vaianella L; Pierguidi L; Floridi A; Mazzotta G; Floridi A; Gallai V
Headache; 2004; 44(10):961-8. PubMed ID: 15546258
[TBL] [Abstract][Full Text] [Related]
11. Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients.
Bellamy JL; Cady RK; Durham PL
Headache; 2006 Jan; 46(1):24-33. PubMed ID: 16412148
[TBL] [Abstract][Full Text] [Related]
12. Calcitonin gene-related peptide in cervicogenic headache.
Frese A; Schilgen M; Edvinsson L; Frandsen E; Evers S
Cephalalgia; 2005 Sep; 25(9):700-3. PubMed ID: 16109051
[TBL] [Abstract][Full Text] [Related]
13. Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods.
Fusayasu E; Kowa H; Takeshima T; Nakaso K; Nakashima K
Pain; 2007 Apr; 128(3):209-214. PubMed ID: 17123735
[TBL] [Abstract][Full Text] [Related]
14. Plasma cytokine levels in migraineurs and controls.
Perini F; D'Andrea G; Galloni E; Pignatelli F; Billo G; Alba S; Bussone G; Toso V
Headache; 2005; 45(7):926-31. PubMed ID: 15985111
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of serum CGRP measurement as a biomarker of chronic migraine: a critical reappraisal.
Lee MJ; Lee SY; Cho S; Kang ES; Chung CS
J Headache Pain; 2018 Jul; 19(1):53. PubMed ID: 30006780
[TBL] [Abstract][Full Text] [Related]
16. Interictal amylin levels in chronic migraine patients: A case-control study.
Irimia P; Martínez-Valbuena I; Mínguez-Olaondo A; Domínguez-Vivero C; Sánchez-Arias JA; Martínez-Vila E; Luquin MR; Leira R
Cephalalgia; 2021 Apr; 41(5):604-612. PubMed ID: 33269952
[TBL] [Abstract][Full Text] [Related]
17. Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks.
Ashina M; Bendtsen L; Jensen R; Schifter S; Olesen J
Pain; 2000 May; 86(1-2):133-8. PubMed ID: 10779670
[TBL] [Abstract][Full Text] [Related]
18. Calcitonin gene-related peptide in peripheral blood as a biomarker for migraine.
Ramón C; Cernuda-Morollón E; Pascual J
Curr Opin Neurol; 2017 Jun; 30(3):281-286. PubMed ID: 28234796
[TBL] [Abstract][Full Text] [Related]
19. Calcitonin gene-related peptide does not cause the familial hemiplegic migraine phenotype.
Hansen JM; Thomsen LL; Olesen J; Ashina M
Neurology; 2008 Sep; 71(11):841-7. PubMed ID: 18779512
[TBL] [Abstract][Full Text] [Related]
20. Can calcitonin gene-related peptide (CGRP) and pentraxin-3 (PTX-3) be useful in diagnosing acute migraine attack?
Vural S; Albayrak L
J Recept Signal Transduct Res; 2022 Dec; 42(6):562-566. PubMed ID: 35895308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]